Literature DB >> 16634791

Immunohistochemical analysis of coeliac mucosa following ingestion of oats.

U Srinivasan1, E Jones, J Carolan, C Feighery.   

Abstract

There is now considerable clinical evidence that oats do not activate coeliac disease. Nonetheless, a reluctance to include oats in the gluten-free diet remains. Because gluten-induced damage is accompanied by activation of the gastrointestinal immune system, the purpose of this study was to investigate if similar changes were induced by oats ingestion. Small intestinal histological sections from 10 patients who ingested 50 g of oats daily for 3 months were investigated for possible evidence of immune activation. Tissue obtained before and after oats challenge was stained with a series of antibodies directed against the following molecules: human leucocyte antigen D-related (HLA-DR), Ki-67, CD25, CD54 [intercellular adhesion molecule 1 (ICAM-1)] and mast cell tryptase. None of the patients developed clinical or laboratory evidence of adverse effects. The distribution of intestinal HLA-DR expression was not affected by oats ingestion and the crypt epithelium remained unstained. In the pre-oats biopsies, the percentage of Ki-67 positive enterocytes, 29.5 +/- 6.9 [95% confidence interval (CI) 13.9-45.0] did not differ significantly from that found in post-oats biopsies, 41.2 +/- 3.7 (95% CI, 32.8-49.6), P = 0.19, not significant. Furthermore, oats ingestion did not alter the number of CD25 positive and tryptase positive cells. Finally, the distribution and intensity of ICAM-1 staining was unchanged by dietary oats. In summary, detailed immunohistological studies of biopsies from patients ingesting oats for 3 months did not reveal evidence of immune activation. Together with other reported findings, this study strengthens the view that oats can be included safely in the diet of gluten sensitive patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16634791      PMCID: PMC1809658          DOI: 10.1111/j.1365-2249.2006.03052.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Expression of the LFA-1 beta 2 integrin (CD11a/CD18) and ICAM-1 (CD54) in normal and coeliac small bowel mucosa.

Authors:  C J Smart; A Calabrese; D J Oakes; P D Howdle; L K Trejdosiewicz
Journal:  Scand J Immunol       Date:  1991-09       Impact factor: 3.487

2.  Polymerase chain reaction (PCR): a possible alternative to immunochemical methods assuring safety and quality of food. Detection of wheat contamination in non-wheat food products.

Authors:  M Allmann; U Candrian; C Höfelein; J Lüthy
Journal:  Z Lebensm Unters Forsch       Date:  1993-03

3.  Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients.

Authors:  L Maiuri; A Picarelli; M Boirivant; S Coletta; M C Mazzilli; M De Vincenzi; M Londei; S Auricchio
Journal:  Gastroenterology       Date:  1996-05       Impact factor: 22.682

4.  [Histochemical and immunohistochemical study of jejunal mucosa cells in children with celiac sprue].

Authors:  R Kotalová; Z Lojda; J Smídová; J Jodl
Journal:  Cesk Pediatr       Date:  1993-07

5.  Gluten stimulation of coeliac mucosa in vitro induces activation (CD25) of lamina propria CD4+ T cells and macrophages but no crypt-cell hyperplasia.

Authors:  T S Halstensen; H Scott; O Fausa; P Brandtzaeg
Journal:  Scand J Immunol       Date:  1993-12       Impact factor: 3.487

6.  Lactase enzyme, detected immunohistochemically, is lost in active celiac disease, but unaffected by oats challenge.

Authors:  U Srinivasan; E Jones; D G Weir; C Feighery
Journal:  Am J Gastroenterol       Date:  1999-10       Impact factor: 10.864

7.  Activated T lymphocytes in the celiac lesion: non-proliferative activation (CD25) of CD4+ alpha/beta cells in the lamina propria but proliferation (Ki-67) of alpha/beta and gamma/delta cells in the epithelium.

Authors:  T S Halstensen; P Brandtzaeg
Journal:  Eur J Immunol       Date:  1993-02       Impact factor: 5.532

8.  A comparison of diets with and without oats in adults with celiac disease.

Authors:  E K Janatuinen; P H Pikkarainen; T A Kemppainen; V M Kosma; R M Järvinen; M I Uusitupa; R J Julkunen
Journal:  N Engl J Med       Date:  1995-10-19       Impact factor: 91.245

9.  Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study.

Authors:  C Catassi; M Rossini; I M Rätsch; I Bearzi; A Santinelli; R Castagnani; E Pisani; G V Coppa; P L Giorgi
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

10.  Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.

Authors:  K E Lundin; H Scott; T Hansen; G Paulsen; T S Halstensen; O Fausa; E Thorsby; L M Sollid
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  3 in total

1.  Immunological indicators of coeliac disease activity are not altered by long-term oats challenge.

Authors:  S E J Cooper; N P Kennedy; B M Mohamed; M Abuzakouk; J Dunne; G Byrne; G McDonald; A Davies; C Edwards; J Kelly; C F Feighery
Journal:  Clin Exp Immunol       Date:  2013-03       Impact factor: 4.330

2.  Diversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity in coeliac disease.

Authors:  Isabel Comino; Ana Real; Laura de Lorenzo; Hugh Cornell; Miguel Ángel López-Casado; Francisco Barro; Pedro Lorite; Ma Isabel Torres; Angel Cebolla; Carolina Sousa
Journal:  Gut       Date:  2011-02-12       Impact factor: 23.059

Review 3.  To Be Oats or Not to Be? An Update on the Ongoing Debate on Oats for Patients With Celiac Disease.

Authors:  Inna Spector Cohen; Andrew S Day; Ron Shaoul
Journal:  Front Pediatr       Date:  2019-09-26       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.